These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
345 related items for PubMed ID: 12664551
1. [Investigation of the activity of the preparation cerbiden against Candida spp]. Hladun NP, Bondarenko AS, Nahorna SS, Smyrnova OV. Mikrobiol Z; 2002; 64(6):57-61. PubMed ID: 12664551 [Abstract] [Full Text] [Related]
2. In vitro antifungal activity of phenylheptatriyne from Bidens cernua L. against yeasts. Rybalchenko NP, Prykhodko VA, Nagorna SS, Volynets NN, Ostapchuk AN, Klochko VV, Rybalchenko TV, Avdeeva LV. Fitoterapia; 2010 Jul; 81(5):336-8. PubMed ID: 19837144 [Abstract] [Full Text] [Related]
3. [Study of the cerbiden spectrum of antifungal activity against fungi pathogenic to humans]. Smirnov VV, Hladun NP, Bondarenko AS, Hahorna SS, Zakharchenko VO. Mikrobiol Z; 2003 Jul; 65(3):70-7. PubMed ID: 12945196 [Abstract] [Full Text] [Related]
4. [Antifungal activity of the components of the drug cerbiden of plant origin]. Smirnov VV, Bondarenko AS, Gladun NP. Mikrobiol Z; 2003 Jul; 65(4):17-22. PubMed ID: 14618782 [Abstract] [Full Text] [Related]
5. In vitro antifungal sensitivity of fluconazole, clotrimazole and nystatin against vaginal candidiasis in females of childbearing age. Khan F, Baqai R. J Ayub Med Coll Abbottabad; 2010 Jul; 22(4):197-200. PubMed ID: 22455297 [Abstract] [Full Text] [Related]
6. In vitro activity of clotrimazole for Candida strains isolated from recent patient samples. Schmidt A. Arzneimittelforschung; 1995 Dec; 45(12):1338-40. PubMed ID: 8595097 [Abstract] [Full Text] [Related]
7. In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis. Pinto PM, Weikert-Oliveira Rde C, Lyon JP, Cury VF, Arantes RR, Koga-Ito CY, Resende MA. Microbiol Res; 2008 Dec; 163(5):579-85. PubMed ID: 16962755 [Abstract] [Full Text] [Related]
8. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006. Yang YL, Wang AH, Wang CW, Cheng WT, Li SY, Lo HJ, TSARY Hospitals. Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773 [Abstract] [Full Text] [Related]
13. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study. Mallié M, Bastide JM, Blancard A, Bonnin A, Bretagne S, Cambon M, Chandenier J, Chauveau V, Couprie B, Datry A, Feuilhade M, Grillot R, Guiguen C, Lavarde V, Letscher V, Linas MD, Michel A, Morin O, Paugam A, Piens MA, Raberin H, Tissot E, Toubas D, Wade A. Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312 [Abstract] [Full Text] [Related]
18. In vitro activity of 6 antifungal agents on candida species isolated as causative agents from vaginal and other clinical specimens. Ellabib MS, ElJariny IA. Saudi Med J; 2001 Oct; 22(10):860-3. PubMed ID: 11744942 [Abstract] [Full Text] [Related]
19. Evaluation of the etest method using Mueller-Hinton agar with glucose and methylene blue for determining amphotericin B MICs for 4,936 clinical isolates of Candida species. Pfaller MA, Boyken L, Messer SA, Tendolkar S, Hollis RJ, Diekema DJ. J Clin Microbiol; 2004 Nov; 42(11):4977-9. PubMed ID: 15528683 [Abstract] [Full Text] [Related]